Triple Therapy for Intermediate-advanced HCC With BDTT (TALENP002)

Clinical trial NCT06602011 · RECRUITING

Trial details

NCT number: NCT06602011
Sponsor: Fujian Provincial Hospital
Status: RECRUITING
Study type: OBSERVATIONAL

Hepatocellular Carcinoma

Start date: 2024-09-30
Primary completion: 2027-07-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.